Energy sensor extends lifespan across species

AMPK, or AMP-activated protein kinase, is one of the central energy sensors in cells. When energy reserves fall, AMPK switches on various maintenance and repair processes. That makes it an attractive target for aging therapies.

Well-known drugs such as metformin activate AMPK indirectly, as a side effect of their impact on cell metabolism. The researchers asked what happens when you activate AMPK directly and specifically, cutting out the middleman. They used a compound called 991, which activates AMPK in a targeted way.

Effect in small organisms, caution for humans

In yeast, worms (Caenorhabditis elegans), and fruit flies (Drosophila melanogaster), treatment led to extended lifespan. In mice, no lifespan effect was measured, but changes in protein profiles associated with slower aging were observed. Those changes are interesting, though they are not the same as a demonstrated increase in longevity.

That distinction matters. Worms, flies, and yeast respond far more strongly to metabolic interventions than mammals do. This has evolutionary reasons: in short-lived species, every adjustment carries more weight. Extrapolation to humans is therefore uncertain.

What this says about AMPK as a target

The study provides proof-of-principle: direct AMPK activation works differently from indirect activation via metformin and appears to produce a more coherent biological signal. That is scientifically meaningful, even if the lifespan effects are modest and species-specific.

For longevity research, it is notable that the protein changes in mice show a pattern resembling that seen in slowly aging animals. Whether that means anything for humans remains speculative for now. The study was published in the journal Aging Cell.

Read the original article